🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is open label, phase 1 clinical study to evaluate the safety, tolerabi...
Status
Completed
Location
Regional State Budgetary Healthcare Institution "Smolensk Regional Clinical Hospital"
Start Date
2018-10-01
Trial ID
NCT03706898
Treatments Being Tested
Dolutegravir (DTG) and lamivudine (3TC) are indicated in combination with o...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-05
Trial ID
NCT02738931
This is a non-inferiority (10% non-inferiority margin), study to assess the...
Status
Completed
Location
Shandukani Research Centre
Start Date
2017-01-16
Trial ID
NCT03122262
Treatments Being Tested
i2-D²EFT substudy is an observational cohort nested within the parent D²EFT...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-02-01
Trial ID
NCT04183738
Treatments Being Tested
This is a phase IV, open label, multicentre trial that will be taking place...
Status
Unknown
Location
Chelsea and Westminster Hospital
Start Date
2014-11
Trial ID
NCT02285374
Treatments Being Tested
This study is designed to estimate the two-way drug interaction between DCV...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03
Trial ID
NCT02082808
Protocol Title: DOLCE: Dolutegravir-Lamivudine for naïve HIV-Infected Patie...
Status
Completed
Location
Fundación Huésped
Start Date
2021-05-17
Trial ID
NCT04880395
This study is designed to demonstrate the non-inferior antiviral activity o...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-08-22
Trial ID
NCT01910402
Treatments Being Tested
MODERATO is a phase III, open-label, randomized, multicenter, non-inferiori...
Status
Unknown
Location
Hôpital de jour, Service des maladies infectieuses, CHU Sourô Sanou
Start Date
2020-09-21
Trial ID
NCT04022967
This is a clinical research study to see if switching to Darunavir/Cobicist...
Status
Withdrawn
Location
Stanford Univerity
Start Date
2016-05
Trial ID
NCT02499978
Treatments Being Tested